Dr. Sarit  Assouline       CML        Chronic Myeloid Leukemia

Assistant Professor
Jewish General Hospital
Department of Oncology
Gerald Bronfman Centre
Montreal, Canada

Trials Involving Sarit Assouline

Publications Authored By Sarit Assouline

Leukemia: articles  by Sarit E. Assouline    - Expertscape

---

CLINICAL TRIALS

A phase 3, multi-center, open-label, randomized study of oral ABL001 versus bosutinib in patients with Chronic Myelogenous Leukemia in chronic phase (CML-CP), previously treated with 2 or more tyrosine kinase inhibitors

ARTICLES

Persistence with generic imatinib for chronic myeloid leukemia: a matched cohort study
January 10, 2019, Haematologica

Early switch to second-line tyrosine kinase inhibitor in chronic myeloid leukemia patients failing to achieve early molecular response
October 2017,  PubMed

A safety evaluation of omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia
September 15, 2016,  PubMed

Unexpected Success of Watch and Wait Strategy in a Ponatinib-Intolerant Patient With Chronic Myeloid Leukemia
 2016, Journal of Oncology Practice

Major discovery on the mechanism of drug resistance in leukemia and other cancers
May 28, 2014, Science Daily 

​Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated with Imatinib
2011, Journal of the National Cancer Institute (JNCI) - Medscape

Monitoring response and resistance to treatment in chronic myeloid leukemia
April 2011, Current Oncology

Alterations in creatine kinase, phosphate and lipid values in patients with chronic myeloid leukemia during treatment with imatinib
February 2008, Haematologica

           See also   CML Experts in Canada - Experts LMC au Canada